Presents Positive Preclinical

Related by string. * pre sented . Presented . presents . presenting : Present Situation Index . Top Gear presenter . Kentucky Derby Presented . Christmas Past Present / Positives . POSITIVE . positives . POSITIVES : Rating Watch Positive . estrogen receptor positive . retrieve false positives . tested positive / preclinical : vivo preclinical . preclinical toxicology . preclinical efficacy * *

Related by context. All words. (Click for frequent words.) 87 Presents Positive 82 Presents Preclinical 81 Completes Patient Enrollment 80 Initiates Phase II 80 Initiates Enrollment 80 Initiates Clinical 80 Initiates Clinical Trial 80 Therapeutic Competitors Companies 79 Reveals Positive 79 Commences Phase 78 Begins Dosing 78 Files IND 78 Receives Orphan Drug Designation 77 Completes Enrollment 77 Successfully Completes Phase 77 Receives Milestone Payment 77 Presents Preclinical Data 77 Therapeutic Competitors companiesandmarkets.com adEgemonye 77 Submits IND 76 Announce License Agreement 76 Initiates Phase III 76 Submits Response 76 Receives Approvable Letter 76 Initiates Clinical Trials 76 Enrolls First 75 Submits NDA 75 Initiates Dosing 75 Collaborators Present 75 Announces Presentation 75 Licenses Novel 75 Achieves Primary Endpoint 74 Reports Preclinical Data 74 Demonstrates Significant 74 Announces Initiation 74 Initiates Phase 74 Meets Primary Endpoint 74 Receives Fast Track 74 Receives Orphan Drug 74 Phase IIb Clinical Trial 74 Inc Therapeutic Competitors 74 Gets FDA Clearance 74 Drug Candidate 73 FDA Clears 73 Demonstrates Positive 73 Submits Biologics License Application 73 Files Shelf Registration Statement 73 Completes Patient Enrolment 73 Reports Positive 73 Announce Collaboration Agreement 73 Phase 2b Clinical Trial 73 Granted Orphan Drug 73 Phase IIa Clinical Trial 73 Announces Tentative Approval 73 Receives NASDAQ 73 Announces FDA Clearance 73 Pivotal Phase III 73 Jumps Higher 73 Initiates Phase 2b 73 BioSante Pharmaceuticals Announces 73 Shows Promising 72 Announces Poster Presentations 72 Present Preclinical Data 72 Announces Positive 72 PRN FDA Approves 72 Collaborators Publish 72 Receives Favorable 72 IG HCR ;) CO 72 Patient Enrollment 72 Investigational Compound 72 Clinical Trial Results 72 FOLOTYN ® 72 Nasdaq IDIX 72 NDA Submission 72 Protease Inhibitor 72 Receive Milestone Payment 72 Awarded Patents 72 Files Investigational 71 Initiate Phase 71 Begins Clinical Trial 71 Immunomedics Announces 71 non nucleoside inhibitor 71 Announces Successful Completion 71 Combination REOLYSIN R 71 Initiate Clinical Trial 71 Commences Phase III 71 Completes Dosing 71 Phase IIb Trial 71 Sign License Agreement 71 Sinks Lower 71 Announces Licensing Agreement 71 Lupus Drug 71 Submits Supplemental 71 Inc. Nasdaq OXGN 71 Significantly Improves 71 Achieves Milestone 71 Novel Oral 71 Earns Milestone Payment 71 Pivotal Phase 71 Prolongs Survival 71 Obtains License 71 Receives FDA Clearance 71 Phase 2a Trial 71 Vaccine Adjuvant 71 Amends Agreement 71 Receives Patent 71 Systemic Delivery 71 please visit http:/www.vandapharma.com 71 JAK2 Inhibitor 70 Preclinical Data 70 Demonstrates Potential 70 Taglich Brothers Initiates Coverage 70 Welcomes Analyst Initiation 70 Announce Merger Agreement 70 VentiRx Pharmaceuticals 70 Drug Fails 70 Announces License Agreement 70 Spectrum Pharmaceuticals Announces 70 Commence Phase 70 Therapeutic Competitors Report 70 Phase III Trial 70 Milestone Payment 70 Receives Positive 70 Announces Publication 70 Receives Complete Response 70 Therapeutic Competitors 70 Nasdaq HALO 70 Submits Application 70 please visit http:/www.atherogenics.com 70 Phase III Clinical Trial 70 R MSCRAMM 70 Receives Tentative Approval 70 Begins Shipment 70 pralatrexate injection folate analogue 70 Hsp# Inhibitor 70 Oral Calcitonin 70 Study Evaluating 70 Kinase Inhibitor 70 REG1 Anticoagulation System 70 Nasdaq PHRM 70 Receives CE Marking 70 TRACON Pharmaceuticals 70 Announce Initiation 70 Alnylam Nasdaq ALNY 70 Xcytrin R 70 Patent Issued 70 FDA Accepts 69 Extends Collaboration 69 Crofelemer budesonide foam 69 Rheumatoid Arthritis Drug 69 BIOTECHNOLOGY SOURCE 69 Single Dose 69 Announces Dosing 69 Files Patent Application 69 Investigational Oral 69 Trial Evaluating 69 Nasdaq XTLB 69 FDA Approvals 69 Launches Generic Version 69 please visit www.dyax.com 69 Lung Cancer Drug 69 Clinical Trial Evaluating 69 Q2 Loss Narrows 69 initiated Phase Ib 69 SWOT Analysis Aarkstore Enterprise 69 NASDAQ ENMD 69 Pivotal Study 69 Q1 Loss Narrows 69 MBRX 69 Awarded Qualifying Therapeutic 69 Nasdaq PGNX 69 TM Aganocide 69 Announce Licensing Agreement 69 Pharmaceuticals Initiates 69 Mylan Receives Approval 69 Study Demonstrates 69 Regains NASDAQ 69 Sign Licensing Agreement 69 SIX RO ROG 69 visit http:/www.mannkindcorp.com 69 platform HDL Mimetic 69 vapreotide acetate 69 Significantly Reduces 69 Licenses Patents 69 Inc SPPI 69 Q3 Loss Widens 69 Phase 2b Trial 69 Receives Clearance 69 Nasdaq EPCT 69 Oncology Compounds 69 Polymerase Inhibitor 68 Nasdaq DVAX 68 Receives SFDA Approval 68 Nasdaq IDEV 68 Cypress Bioscience Inc 68 Completes Merger With 68 NRGN 68 Shows Efficacy 68 TRANSDUR ® 68 Submits Investigational 68 NYSE Amex PBTH 68 TRANSDUR ™ 68 Shareholders Approve Acquisition 68 Omacetaxine 68 Monoclonal Antibody 68 Develop Novel 68 Small Molecule 68 Patients Treated With 68 Regains Full 68 Demonstrates Ability 68 Canaccord Genuity Maintains Hold 68 HCV Protease Inhibitor 68 NeutroPhase TM 68 NASDAQ IDRA 68 Achieves Positive 68 Telik logo TELINTRA 68 Adjunctive Therapy 68 Anti Tumor 68 Roche OTC RHHBY 68 Announces Favorable 68 VIVUS Announces 68 ORADUR ® 68 Orally Active 68 Q4 Loss Narrows 68 Confirms Efficacy 68 Phase III Pivotal 68 FDA APPROVES 68 Regains Compliance With 68 DRRX 68 Recombinant Human 68 Nasdaq TARG 68 Veronate R 68 Transdermal Patch 68 Parathyroid Hormone 68 Significantly Increases 68 Receives Regulatory 68 Vicriviroc 68 Successfully Completes Acquisition 68 Obtains Approval 68 Q2 Adj 68 Finalizes Purchase 68 Attracting Bullish Investors 68 Receives Positive Opinion 68 Report companiesandmarkets.com adds 68 FDA Okays 68 Nasdaq SGEN 68 Inc. OTCBB ALRX 68 combines bupropion 68 Elagolix 68 Q4 Loss Widens 68 Syntonix Pharmaceuticals 68 MEMY 68 Announces Divestiture 68 NASDAQ IDIX 68 proprietary intravenous formulation 68 Vascular Disrupting Agent 68 Nasdaq PARD 68 IND Application 68 Earnings Postmortem 68 OTC BB PVCT 68 developing ACAPODENE 68 First Patient Enrolled 68 Secures Additional 68 RNAi Therapeutic 68 Strengthens Balance Sheet 68 Announces Issuance 68 Issued Patent 68 hyaluronidase enzyme 68 Restructures Operations 68 Aloxi ® 68 First Patient Treated 68 VIVITROL ® 68 Vitrasert R 68 Obtains Exclusive License 67 Q3 Loss Narrows 67 Retains CCG Investor Relations 67 TO AVOID PREGNANCY WHILE 67 Agonist MABA program 67 please visit http:/www.supergen.com 67 Personalized Immunotherapy 67 Pegloticase 67 NASDAQ ADLR 67 Develops Novel 67 Anti CD# Antibody 67 Mg Usa 67 Receives Unsolicited 67 OTCBB HNAB 67 novel emulsion formulation 67 Drug Shows Promise 67 Receives Approvals 67 OTCBB GETA 67 TSX NVN 67 Q2 Loss Widens 67 Successfully Completes Tender Offer 67 Sapacitabine 67 Lanthanum Carbonate 67 Atripla combines 67 Taro Receives 67 Completes Tender Offer 67 Severe Sepsis 67 visit www.genenews.com 67 WeissComm Partners +#-#-#-# 67 TELINTRA R 67 Acquire Assets 67 Testosterone MDTS ® 67 Receives Conditional 67 Namenda Memantine HCl 67 Cypher Sirolimus 67 Improves Outcomes 67 Phase 1b Clinical Trial 67 Provides Update Regarding 67 Announces Effective Date 67 HCV RNA polymerase 67 Detailed Product 67 novel proprietary KL4 67 Tibotec BVBA 67 CD# CEA 67 Begin Clinical Trials 67 Bullish Average Crossover 67 Receives Tentative FDA 67 SPRYCEL ® 67 markets HP Acthar 67 please visit www.medicinova.com 67 Xoma Ltd 67 Pivotal Trial 67 Shows Promise Against 67 Psoriasis Drug 67 Tech DVAX 67 Subsidiary Enters 67 Acquire Privately Held 67 Data Suggest 67 Patent Covering 67 Matrix Phase 2b 67 NASDAQ CRTX 67 Prodrug 67 Nasdaq AVNC 67 Improves Survival 67 Desvenlafaxine Succinate 67 Subsidiaries Selected Financial 67 researches develops licenses 67 submitted Biologics License 67 Reports Receipt 67 ASE SVA 67 RANK Ligand inhibitor 67 NASDAQ EMIS 67 Ozarelix 67 Brentuximab Vedotin SGN 67 UGNE 67 Secures Financing 67 PharmaVitae Profile 67 OTCBB ILNS 67 Milestone Payments 67 lead molecular radiotherapeutic 67 Finalizes Acquisition 67 NASDAQ IDEV 67 P#X# antagonist 67 Osteoporosis Drug 67 visit www.targanta.com 67 Enters Into License Agreement 67 euro adhoc Intercell AG 67 Biomarker Study 67 Q1 Adj 67 Flamel Technologies Announces 67 programs visit http:/www.bionovo.com 67 Appoints Seasoned 67 NASDAQ MIPI 67 Tezampanel 67 Ltd Therapeutic Competitors 67 OTCBB PYTO 67 Inc. www.micromet inc.com 67 Medisorb ® 67 Biopharmaceuticals AG 67 Announces Early Termination 67 Schizophrenia Drug 67 FDA Approves 67 Awarded Patent 67 Genentech sanofi aventis 67 Nasdaq ACHN 67 highly purified pasteurized 67 Inc. Nasdaq MITI 67 Dry Powder Inhalers 67 Inc FRX FRX 67 Therapeutic Antibody 67 Skymark Research Initiates Independent 67 visit http:/www.PAREXEL.com 67 Amend Merger Agreement 66 Preclinical Study 66 Reacquires 66 Expands Portfolio 66 PWRM.OB 66 Puts Purchased 66 Investigational Treatment 66 Board Authorizes 66 OTCBB GNTA 66 Enters Into Collaboration 66 GTC NASDAQ GTCB 66 Confirms Filing 66 Antibody Drug Conjugate 66 Bearish MACD 66 acetonide FA 66 Vidaza R 66 Gene Expression Analysis 66 Migraine Drug 66 Demonstrates Statistically Significant 66 Treatment Naïve 66 NASDAQ ARRY 66 Gendux AB 66 albiglutide 66 AMEX KAL 66 Inflammatory Arthritis 66 HuCAL GOLD R 66 Patents Covering 66 NasdaqGM NTEC today 66 NASDAQ BDSI 66 Calls Purchased 66 Novartis Novo Nordisk 66 Nasdaq IMGN 66 Initiate Phase III 66 Board Unanimously Rejects 66 NASDAQ ONXX 66 Nasdaq CYTX 66 ABLYNX 66 SPL# Gel vaginal microbicide 66 NASDAQ LGND 66 Completes Previously Announced 66 Patient Enrolment 66 Signs Merger Agreement 66 Widens Quick Facts 66 investigational humanized monoclonal antibody 66 visit www.noven.com 66 Terminate Merger Agreement 66 Joins OTCQX 66 Enters Into Licensing Agreement 66 Telaprevir VX 66 BUPHENYL R 66 Successfully Closes 66 By JAMAAL ABDUL 66 Nasdaq MYRX 66 Enzon Pharmaceuticals Inc 66 Japanese Encephalitis Vaccine 66 Provides Updated 66 MOVIPREP R 66 Ecallantide 66 Achieves SAS 66 Gout Drug 66 Trastuzumab DM1 66 Endures Analyst Downgrade 66 Momenta Pharmaceuticals MNTA 66 Guides Inline 66 NASDAQ CGPI 66 Nasdaq OSIP 66 Aldara ® 66 Corp. ADLR 66 Inc. Nasdaq IMGN 66 lexidronam injection 66 Flagship Product 66 Announces Postponement 66 CONFERENCE CALLS SOURCE 66 Anticancer Agent 66 AUDIO PROVIDED BY 66 Nasdaq VRTX today 66 Introduces Next Generation 66 MEK Inhibitor 66 Introduces Novel 66 Strengthens Position 66 IND Filing 66 Randomized Phase 66 Obtains FDA 66 Rylomine 66 Achieves Record Revenue 66 Transcept Pharmaceuticals 66 Receives Notice Related 66 Q4 Profit Decreases 66 Settle Patent Litigation 66 Announce Early Termination 66 Alfacell proprietary ribonuclease 66 candidates Azedra TM 66 Sangamo BioSciences Announces 66 Announces Adjournment 66 Pharma Merck Serono 66 Q1 Loss Widens 66 Sign Definitive Merger 66 Luveris R Ovidrel R 66 NASDAQ ISIS 66 Nasdaq VNDA 66 NewsBite Downgrade Puts Pressure 66 INDICATED LOWER 66 Anti Tumor Activity 66 EMD Biosciences Inc. 66 Potelligent Technology 66 Shows Statistically Significant 66 RDYN 66 Sirna Therapeutics StrataCom 66 Inc ALKS 66 Post Earnings Checkup 66 Expand Collaboration 66 PHRM 66 Signs Agreements 66 Nasdaq PPHM clinical 66 includes Dideco CarboMedics 66 Nitazoxanide 66 Bosutinib 66 Pivotal Trials 66 Inc. NASDAQ SIRT 66 molecular imaging radiopharmaceutical 66 Pending Acquisition 66 Guides Below 66 telomerase therapeutic 66 Announce Receipt 66 Aradigm Logo 66 PROFILE CO 66 Nasdaq CADX 66 Phase III Clinical Trials 66 Completes Recapitalization 66 Host Fourth Quarter 66 Nasdaq NBIX 66 Completes Financing 66 Updates Guidance 66 Refractory Hodgkin Lymphoma 66 Civacir 66 Bearish Speculation 66 Treatment Resistant 66 Releases Third Quarter 66 Terminates Agreement 66 Announces Stockholder Approval 66 Canaccord Genuity Reiterates Buy 66 evaluating tivozanib 66 Advanced Melanoma 66 refractory chronic lymphocytic 66 Ridaforolimus 66 Restructures Debt 66 Celgene Thalomid 66 Q4 Profit Soars 66 Moving Average Crossover Alert 66 developing Zerenex ferric 66 Acquires Exclusive 66 Releases Next Generation 65 AllPennyStocks.com Spotlights 65 Nasdaq BCRX 65 Plaque Psoriasis 65 Paris IPN Euronext 65 Nicotine Vaccine 65 gets USFDA nod 65 Corp. PHRM 65 Shows Promise 65 Release Capsules 65 Signs License Agreement 65 Pooled Analysis 65 Gets Bearish Confirmation 65 NGSX 65 Nasdaq KERX 65 Nasdaq IDRA today 65 Pivotal Clinical Trial 65 Commercialize Novel 65 subsidiaries visit http:/www.apricusbio.com 65 Arthritis Drug 65 TKPHF 65 novel MetAP 2 65 Rated Speculative Buy 65 Demonstrates Potent 65 ANIK 65 Exercises Option 65 Successfully Completed 65 Aztreonam Lysine 65 Nasdaq SLXP 65 mGluR2 positive 65 Penwest Pharma 65 midstage clinical 65 PF # [002] 65 NASDAQ INGN 65 ® bortezomib 65 NASDAQ AVNR 65 Potent Antiviral Activity 65 LGND 65 Bullish Technical Alert 65 novel orally inhaled 65 telomerase inhibitor drug 65 THE RUN DOWN 65 Bullish Speculation 65 NASDAQ MOGN 65 Demonstrates Sustained 65 Successfully Concludes 65 TKB# 65 Receives ISO #:# [002] 65 RNAi Therapeutics 65 Explores Strategic Alternatives 65 Announces Discontinuation 65 Receives Anticipated 65 intranasal formulation 65 liposomal formulation 65 Study Showed 65 :/ finance.yahoo.com q 65 narrows Quick Facts 65 CONTINUES LOWER 65 targeted radiotherapeutic 65 AAG geldanamycin analog 65 pharmacogenomic translational research 65 Nasdaq ACAD 65 Hold Third Quarter 65 Diabetic Foot Ulcer 65 Puts Sold 65 Phase III Trials 65 Generic Versions 65 dependent kinase inhibitor 65 Commercializes 65 Exploit collaboration 65 FY# Loss Widens 65 Previously Treated 65 Antimicrobial Coating 65 Million Milestone Payment 65 MKC# MT 65 Nasdaq RDEA 65 Hormone Refractory Prostate Cancer 65 Extend Collaboration 65 Maribavir 65 Exherin 65 Inc. NASDAQ OXGN 65 Jointly Announce 65 Pafuramidine 65 Tyrosine Kinase Inhibitor 65 IL# PE#QQR 65 Kelly Luethje #-#-# 65 Achieves ISO #:# Certification [002] 65 OTCBB IGXT 65 Nasdaq CTIC 65 NASDAQ NRGN 65 AFREZZA TM 65 Fast Track Status 65 Corp. AMEX CVM 65 Closes Merger 65 CRTX 65 Crucell NV NYSE Euronext 65 Abstract Accepted 65 NASDAQ CRXL 65 Targanta Therapeutics Corporation 65 AMEX RGN 65 Phase Ib II 65 Q2 Profit Surges 65 Levoleucovorin 65 Cadence Pharmaceuticals Inc 65 Inotek Pharmaceuticals Corporation 65 OPXA 65 OTCBB DORB 65 NASDAQ TARG 65 NOTE POSIDUR ™ 65 Receives Approval From 65 Guides Above 65 Guides FY# Quick Facts 65 Delivers Next Generation 65 Partnering Agreements 65 Achieves Significant 65 Molecular Diagnostic Test 65 COLAZAL R 65 IDIX 65 PROLOR Biotech Inc. 65 Announce Licensing 65 ELADUR ™ 65 otcstockexchange.com 65 Preclinical Testing 65 NASDAQ PCYC 65 successfully commercialize Iluvien 65 PAION AG ISIN 65 Webcast Presentations 65 Immunotherapeutic 65 vinorelbine tartrate 65 Revises Guidance 65 BIOV 65 ALN HPN 65 PSDV 65 Inc. NASDAQ SUPG 65 Nasdaq IMMU 65 treat chronic sinusitis 65 NASDAQ IMGN 65 SWOT Analysis http:/www.companiesandmarkets.com aJEH MacDonald 65 Net Loss Narrows 65 Nasdaq NPSP 65 Voluntarily Withdraws 65 Reduces Risk 65 TSX CTI 65 Explore Strategic Alternatives 65 Nasdaq GNTA 65 technology visit http:/www.genmab.com 65 Completes Acquisitions 65 class anticancer quinolone 65 CysDisplay R 65 Inc. NASDAQ SGEN 65 Nasdaq PANC 65 GlaxoSmithKline MedImmune 65 Disease Modifying 65 OTC BB EMIS 65 Regains Compliance 65 NASDAQ ALNY 65 Announce Reseller Agreement 65 Provides Comprehensive 65 product candidate Lpathomab 65 Q1 Profit Surges 65 KAI Pharmaceuticals Inc. 65 JAK Inhibitor 65 Stockholders Approve Acquisition 65 Nasdaq ANPI 65 visit http:/www.neogenomics.org 65 Ceflatonin R 65 Kosan dependence 65 Settles Patent Litigation 65 TSPT 65 OTCBB IMUC 65 Nasdaq SMTS develops manufactures 65 Buy Privately Held 65 Cholesterol Lowering Drug 65 Demonstrated Significant 65 Inc. Nasdaq SEPR 65 Provides Updates 65 Voluntarily Withdraw 65 Nasdaq MRNA 65 Gonal f R 65 Ovitrelle R Serostim 65 Long Term Efficacy 65 Crosses Above 65 Successfully Completes 65 Significantly Improved 65 License Application sBLA 65 OTCStockExchange.com Stock Alert 65 Genentech Wyeth Pharmaceuticals 65 Miscellaneous #.#.# Release 65 Phase Ib Clinical Trial 65 markets Testim ® 65 Settles Litigation 65 BayStreet.ca Research Alert 65 Nasdaq ABII 65 Transdermal System 65 Introduces Enhanced 65 Clinical Study Shows 65 Oral Insulin 65 BTRX 65 rxRNA 65 Dynepo TM 65 Broadens Its 65 NASDAQ KERX 65 proprietary radiolabeled monoclonal 65 Ltd. OTCBB IMUC 65 Genes Involved 65 Mutually Agree 65 NASDAQ VRUS 65 GVAX ® 65 CCR5 mAb 65 Pruvel TM 65 Signs Licensing Agreement 65 outlicensed 65 Completes Initial 65 SABER ™ 65 Biogen Genentech 65 TM pralatrexate injection 65 SAR# [002] 65 Phase 2a Clinical Trial 65 novel histone deacetylase 65 Merck OSI Pharmaceuticals 65 Showed Significant 65 THERAPEUTICS 65 mertansine 65 Receives Commitment 65 Nasdaq ONXX 65 Regains Nasdaq 65 NASDAQ REGN 65 Sunesis Pharma 65 Stockholders Approve Merger 65 GILD GILD 65 Enters Into Definitive 65 Bradmer Pharmaceuticals 65 NicVAX TM 65 MONSTERSTOX.COM Monsterstox.com 65 Helps Predict 65 Completes Reverse Merger 65 4SC AG ISIN DE# 65 StockPreacher.com Issues Trading 65 LymphoStat B TM 65 Extends Expiration Date 65 Settles Patent Dispute 65 OTCBB HXBM developer 65 AMEX ISV 64 Receptor Agonist 64 Antitumor Activity 64 Nasdaq ENMD 64 Unveils Breakthrough 64 developing Bicifadine serotonin 64 Nasdaq NRGN 64 Nasdaq VVUS 64 Intravenous Human 64 Predictive medicine 64 Provides Shareholder 64 nasal decolonization 64 ONCY 64 Array Biopharma 64 Lupus Nephritis 64 NASDAQ ACOR 64 apricitabine ATC 64 website www.celsion.com 64 Shareholders Approve Merger Agreement 64 Completes Transaction 64 Canaccord Genuity Maintains Buy 64 MBRK 64 Identifies Potential 64 Genentech GlaxoSmithKline 64 Announce Commencement 64 Staphylococcus aureus Immune Globulin 64 Lowers Guidance 64 peptidic compound 64 Report Initiates Independent 64 visit www.stemcellthera.com 64 HDAC Inhibitor 64 Cardioxyl Pharmaceuticals 64 NASDAQ ALXA 64 Nasdaq IDRA 64 SinuNase ™ 64 Blood Pressure Drug 64 markets COLAZAL 64 Nasdaq PPHM 64 Friedreich Ataxia FRDA 64 agonistic human 64 Introduces Expanded 64 Adjuvant Treatment 64 R lenalidomide 64 oral renin inhibitor 64 nucleotide analog 64 Systemic Sclerosis 64 SGXP 64 OTCBB NNVC 64 Locteron exclusively 64 Bearish Pressure Building 64 Supernus Pharmaceuticals 64 superparamagnetic iron oxide nanoparticles 64 NASDAQ DSCO 64 pentadentate logo R 64 Settle Patent Dispute 64 include Altastaph TM 64 Dose Ranging Study 64 DURECT proprietary 64 Diabetic Neuropathy 64 AMEX PTN 64 Romiplostim 64 Closes Previously Announced 64 Consummates 64 Changes Ticker Symbol 64 Amex PTN 64 product platforms AZX# 64 MEDW 64 Invites Investors 64 NASDAQ BMRN 64 Closes Acquisition 64 PPD Declares 64 Nasdaq CYCC 64 Ondansetron Orally Disintegrating Tablets 64 Inc. NASDAQ ORXE 64 KAI Pharmaceuticals 64 Nasdaq MITI 64 Inc GHDX 64 Q3 Adj 64 MCSP respectively 64 oncolytic virus therapies 64 Hematological Malignancies 64 NOVN 64 ASX PGL 64 MNOV 64 Safinamide 64 NASDAQ VRTX 64 Generic Version 64 methylnaltrexone bromide 64 Reschedules Fourth Quarter 64 Biotherapeutic 64 Inc POZN 64 Takeda Kyowa Hakko Kirin 64 Corp EPCT 64 Inc. LATEST NEWS 64 CybeRelease Decliners 64 Hedgehog Pathway Inhibitor 64 orally inhaled migraine 64 NASDAQ RNAI 64 ROSG 64 Vivecon 64 Milestone Payment From 64 ARYX 64 Catalyst Biosciences 64 Sets Record Date 64 Updates Status 64 Prodarsan R 64 Mg Uk 64 Inc. Nasdaq SUPG 64 Pulmonary Arterial Hypertension 64 NYSE Amex PTN 64 NASDAQ SLXP 64 Receives Certification 64 Nasdaq AEGR 64 Posts Wider Loss 64 Tobira Therapeutics 64 TTHI 64 Aurora Kinase 64 Onyx Pharmaceuticals Announces 64 NEXM 64 Novel Antibiotic 64 LSE SHP.L 64 DayTradersDigest.com Profiles 64 GTOP 64 ® adefovir dipivoxil 64 Intravitreal 64 Inc FRX 64 Corp. Nasdaq GENZ 64 Inc. NASDAQ MRNA 64 candidate MyVax 64 Receives Funding 64 NASDAQ CPHD 64 INSPIRE Trial Phase III 64 Signs Option Agreement 64 Advancis Pharmaceutical Corporation 64 Files Shelf Registration 64 Hydrochlorothiazide Tablets 64 Unveils Revolutionary 64 Subsidiary Receives 64 Expands Scope 64 Copegus R 64 AMEX DDD 64 NASDAQ OMER 64 ARDM 64 please visit www.abraxane.com 64 Nasdaq AUXL 64 Q4 Profit Surges 64 Prostate Cancer Vaccine 64 Issues Guidance 64 ALPMF 64 LymphoStat B belimumab 64 topical gel formulation 64 Valera Pharmaceuticals 64 Reduces Debt 64 Tumor Targeting 64 Isis Pharma 64 proprietary intranasal insulin 64 Drug Formulation 64 Acquirer Company 64 Antisense Drug 64 NDQ 64 R roscovitine CDK cyclin 64 OTCBB CHKT 64 TSRX 64 Announces Stock Repurchase 64 5q MDS 64 Maven Semantic 64 Incyte Corp 64 topically administered 64 Evoltra ® 64 Epilepsy Drug 64 Closes Acquisition Of 64 Announces Resumption 64 VSNT 64 Completes Reorganization 64 http:/www.sunesis.com 64 Record Third Quarter 64 Demonstrates Efficacy 64 brivanib 64 PFE PFE 64 Reports Significantly Improved 64 Vertebral Fracture 64 OTCBB AMAR 64 Announces Definitive Agreement 64 evaluating mipomersen 64 Antiviral Activity 64 ATRA IV 64 Declares Increase 64 non nucleoside HCV 64 Closes Financing 64 COMPLETES ACQUISITION OF 64 Successfully Integrates 64 Preclinical Models 64 Enters Definitive Agreement 64 Provides Guidance 64 Medoxomil 64 Provides Clarification 64 www.telik.com 64 Solteq Oyj 64 PENNY STOCK ON 64 Testosterone MDTS R 64 TSX VENTURE SLX OTCBB 64 INDICATED HIGHER 64 MEDICAL PHARMACEUTICAL 64 -Pahuta 64 Proposed Buyout 64 Combination Treatment 64 OTCBB NPHC 64 NYMX 64 please visit www.eisai.com 64 oral prodrug 64 Genotyping Test 64 investigational oral inhibitor 64 www.pharsight.com 64 IMiDs ® 64 Host Second Quarter 64 Combination Therapy 64 Completes Buyout 64 5 HT3 antagonist 64 Receives Marketing Authorization 64 NASDAQ VVUS 64 Inc NGSX 64 Cyclacel Pharmaceuticals

Back to home page